Clinical Trials Logo
  1. Home
  2. Thoracic Aortic Dissection
  3. NCT05771831

Thrombosomes® in Acute Thoracic Aortic Dissections — TTAD  

Thoracic Aortic Dissection Clinical Trial

Official title:
Feasibility and Safety of Thrombosomes® on Time to Hemostasis in Patients Undergoing Emergency Surgery for Thoracic Aortic Dissections - a Randomized, Controlled, Open-label Investigator-initiated Pilot Trial

Clinical Trial Summary

The hypothesis is that administration of Thrombosomes® (TBX®) as hemostatic support when terminating the cardiopulmonary bypass (CPB) in patients undergoing emergency surgery for acute thoracic aortic dissection (aTAD) is safe and least as effective when compared to standard Platelet Concentrates (stPC).

Clinical Trial Description

The study is designed as an exploratory phase 2a, single-center randomized, controlled pilot investigator-initiated trial of administration of Thrombosomes® (TBX®) versus standard platelet concentrates (stPC) in 20 aTAD patients per arm. The patients will be enrolled in the study over a period of 15 months. TBX® is a novel, human platelet (thrombocyte) derived lyophilized (freeze dried) hemostatic blood product for treatment of bleeding due to thrombocytopenia, dysfunctional platelet disorders or platelet consumption. The patients will be randomized to administration of either TBX®, or stPC, as part of the Massive Transfusion Protocol (MTP) at the time of termination of the cardiopulmonary bypass (CPB) in addition to standard goal-directed hemostatic optimization based on results from thrombelastography (TEG). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05771831
Study type Interventional
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase Phase 2
Start date March 15, 2023
Completion date April 11, 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT06270537 - Post-market Clinical Trial of the Dominus® Stent-Graft
Completed NCT00597870 - Physician-Sponsored IDE for the Talent Endoluminal Stent Graft System for the Treatment of Thoracic Lesions N/A
Recruiting NCT05639400 - Thoraflex Hybrid and Relay Extension Post-Approval Study
Active, not recruiting NCT04267055 - DISSECT-N Post Market Data Collection Registry
Completed NCT05414318 - CTAG Dissection/Trauma Post Marketing Surveillance Japan
Active, not recruiting NCT05610462 - Trial of Exercise in Aortic Dissection Survivors N/A
Recruiting NCT05309707 - ENDOBARC-S Study: "Endovascular Branched Stent-grafts for Aortic ARCh Pathologies in Spain"
Recruiting NCT06336213 - Antibacterial Tactics Based on Presepsin Level in Thoracic Aorta Surgery Patients N/A
Enrolling by invitation NCT03767777 - Prospective Study for Aortic Arch Therapy With stENt-graft for Chimney technologY（PATENCY） N/A
Enrolling by invitation NCT05155956 - Cerebral Hemodynamics and Microemboli During Placement of Relay®Branch Thoracic Stent-Graft System
Recruiting NCT03440697 - Pathogenetic Basis of Aortopathy and Aortic Valve Disease